Hesperidin Suppresses Ovalbumin-Induced Airway Inflammation in a Mouse Allergic Asthma Model
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bochner, B.S., and W.W. Busse. 2004. Advances in mechanisms of allergy. The Journal of Allergy and Clinical Immunology 113: 868–875.
Bochner, B.S., and W.W. Busse. 2005. Allergy and asthma. The Journal of Allergy and Clinical Immunology 115: 953–959.
Busse, W.W. 1993. Calhoun William WF, Sedgwick JD. Mechanism of airway inflammation in asthma. The American Review of Respiratory Disease 147: S20–S24.
Ngoc, P.L., D.R. Gold, A.O. Tzianabos, S.T. Weiss, and J.C. Celedon. 2005. Cytokines, allergy, and asthma. Current Opinion in Allergy and Clinical Immunology 5: 161–166.
Zhu, Z., R.J. Homer, Z. Wang, Q. Chen, G.P. Geba, J. Wang, et al. 1999. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. Journal of Clinical Investigation 103: 779–788.
Zavorotinskaya, T., A. Tomkinson, and J.E. Murphy. 2003. Treatment of experimental asthma by long-term gene therapy directed against IL-4 and IL-13. Molecular Therapy 7: 155–162.
Takatsu, K., and H. Nakajima. 2008. IL-5 and eosinophilia. Current Opinion in Immunology 20: 288–294.
Busse, W., J. Corren, B.Q. Lanier, M. McAlary, A. Fowler-Taylor, G.D. Cioppa, et al. 2001. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. The Journal of Allergy and Clinical Immunology 108: 184–190.
Djukanovic, R., S.J. Wilson, M. Kraft, N.N. Jarjour, M. Steel, K.F. Chung, et al. 2004. Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma. American Journal of Respiratory and Critical Care Medicine 170: 583–593.
Bousquet, J., P. Cabrera, N. Berkman, R. Buhl, S. Holgate, S. Wenzel, et al. 2005. The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma. Allergy 60: 302–308.
Murakami, A., Y. Nakamura, K. Torikai, T. Tanaka, T. Koshiba, K. Koshimizu, et al. 2000. Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in mice. Cancer Research 60: 5059–5066.
Sato, T., L. Koike, Y. Miyata, M. Hirata, Y. Mimaki, Y. Sashida, et al. 2002. Inhibition of activated protein-1 binding activity and phosphatidylinositol 3-kinase pathway by nobiletin, a polymethoxy flavonoid, results in augmentation of tissue inhibitor of metalloproteinase-1 production and suppression of production of matrix metalloproteinases 1 and 9 in human fibrosarcoma HT-1080 cells. Cancer Research 62: 1025–1029.
Miyata, Y., T. Sato, M. Yano, and A. Ito. 2004. Activation of protein kinase CβII/ε-c-Jun NH2-terminal kinase pathway and inhibition of mitogen-activated protein/extracellular signal-regulated kinase1/2 phosphorylation in antitumor invasive activity induced by the polymethoxy flavonoid, nobiletin. Molecular Cancer Therapeutics 3: 839–847.
Barthe, G.A., P.S. Jourdan, C.A. McIntosh, and R.L. Mansell. 1988. Radioimmunoassay for the quantitative determination of hesperidin and analysis of its distribution in Citrus sinensis. Phytochemistry 27: 249–254.
Garg, A., S. Garg, L.J.D. Zaneveld, and A.K. Singla. 2001. Review article: chemistry and pharmacology of the citrus bioflavonoid hesperedin. Phytotherapy Research 15: 655–669.
Bok, S.H., S.H. Lee, Y.B. Park, K.H. Bae, K.H. Son, T.S. Jeong, et al. 1999. Plasma and hepatic cholesterol and hepatic activities of 3-hydroxy-3-methyl-glutaryl-CoA reductase and acyl CoA: cholesterol transferases are lower in rats fed citrus peel extract or a mixture of citrus bioflavonoids. The Journal of Nutrition 129: 1182–1185.
Hirata, A., Y. Murakami, M. Shoji, Y. Kadoma, and S. Fujisawa. 2005. Kinetics of radical-scavenging activity of hesperetin and hesperidin and their inhibitory activity on COX-2 expression. Anticancer Research 25: 3367–3374.
Yeh, M.H., S.T. Kao, C.M. Hung, et al. 2009. Hesperidin inhibited acetaldehyde-induced matrix metalloproteinase-9 gene expression in human hepatocellular carcinoma cells. Toxicology Letters 184: 204–210.
Park, S.H., E.K. Park, and D.H. Kim. 2005. Passive cutaneous anaphylaxis-inhibitory activity of flavanones from Citrus unshiu and Poncirus trifoliata. Planta Medica 71: 24–27.
Middleton, R., and G. Drzewiecki. 1984. Flavonoid inhibition of human basophil histamine release stimulated by various agents. Biochemical Pharmacology 33: 3333–3338.
Kim, H.P., K.H. Son, H.W. Chang, and S.S. Kang. 2004. Anti-inflammatory plant flavonoids and cellular action mechanisms. Journal of Pharmacological Sciences 96: 229–245.
Yeh, C.C., S.J. Kao, C.C. Lin, et al. 2007. The immunomodulation of endotoxin-induced acute lung injury by hesperidin in vivo and in vitro. Life Science 80: 1821–1831.
Kawaguchi, K., S. Kikuchi, R. Hasunuma, et al. 2004. A citrus flavonoid hesperidin suppresses infection-induced endotoxin shock in mice. Biological & Pharmaceutical Bulletin 27(5): 679–683.
Kim, J.Y., Y.P. Hwang, D.H. Kim, et al. 2006. Inhibitory effect of the saponins derived from roots of Platycodon grandiflorum on carrageenan-induced inflammation. Bioscience, Biotechnology, and Biochemistry 70: 858–864.
Ahn, K.S., E.J. Noh, H.L. Zhao, et al. 2005. Inhibition of inducible nitric oxide synthase and cyclooxygenase II by Platycodon grandiflorum saponins via suppression of nuclear factor-kappa B activation in RAW 264.7 cells. Life Science 76: 2315–2328.
Fish, S.C., D.D. Donaldson, S.J. Goldman, et al. 2005. IgE generation and mast cell effector function in mice deficient in IL-4 and IL-13. Journal of Immunology 174: 7716–7724.
Patricia, C., and C. Fulkerson. 2006. Eosinophils and CCR3 regulate interleukin-13 transgene-induced pulmonary remodeling. The American Journal of Pathology 169(6): 2117–2126.
Wakahara, K., H. Tanaka, G. Takahashi, et al. 2008. Repeated instillations of Dermatophagoides farinae into the airways can induce Th2-dependent airway hyperresponsiveness, eosinophilia and remodeling in mice: effect of intratracheal treatment of fluticasone propionate. European Journal of Pharmacology 578: 87–96.
Cockcroft, D.W., and B.E. Davis. 2006. Mechanisms of airway hyperresponsiveness. The Journal of Allergy and Clinical Immunology 118: 551–559.
Hart, L.A., V.L. Krishnan, I.M. Adcock, P.J. Barnes, and K.F. Chung. 1998. Activation and localization of transcription factor, nuclear factor-κB, in asthma. American Journal of Respiratory and Critical Care Medicine 158: 1585–1592.
Vargaftig, B.B., and M. Singer. 2003. Leukotrienes mediate murine bronchopulmonary hyperreactivity, inflammation, and part of mucosal metaplasia and tissue injury induced by recombinant murine interleukin-13. American Journal of Respiratory Cell and Molecular Biology 28: 410–419.